[go: up one dir, main page]

AR248283A1 - Procedimiento para preparar nuevos derivados de 2'-halometiliden, 2'-etiniliden y 2'-etiniladenosina, inhibidores de la transmetilacion dependiente de adomet. - Google Patents

Procedimiento para preparar nuevos derivados de 2'-halometiliden, 2'-etiniliden y 2'-etiniladenosina, inhibidores de la transmetilacion dependiente de adomet.

Info

Publication number
AR248283A1
AR248283A1 AR89315002A AR31500289A AR248283A1 AR 248283 A1 AR248283 A1 AR 248283A1 AR 89315002 A AR89315002 A AR 89315002A AR 31500289 A AR31500289 A AR 31500289A AR 248283 A1 AR248283 A1 AR 248283A1
Authority
AR
Argentina
Prior art keywords
halomethylidene
ethenylidene
novel
adenosine derivatives
formula
Prior art date
Application number
AR89315002A
Other languages
English (en)
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of AR248283A1 publication Critical patent/AR248283A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR NUEVOS DERIVADOS DE ADENOSINA, INHIBIDORES DE LA TRANSMETILACION DE ADOMET, DE FORMULA (I), DONDE UNO DE X1 Y X2 ES HIDROGENO O HALOGENO Y EL OTRO ES HALOGENO, O EN CONJUNTO, X1 Y X2 CON UN GRUPO > CHR DONDE R ES HIDROGENO O ALQUILO, QUE COMPRENDE SEPARAR LOS GRUPOS TETRAALQUILSILOXANOS EN LOS COMPUESTOS DE FORMULA (II), DONDE RA A RD SON ALQUILO, HACIENDOLOSREACCIONAR CON SALES DE ANION FLUORURO PARA FORMAR LOS COMPUESTOS DE FORMULA (IB) Y HACER REACCIONAR LOS COMPUESTOS (IB) CON AMONIACO PARA INTRODUCIR EL GRUPO - NH2 Y FORMAR LOS CORRESPONDIENTESCOMPUESTOS DE ADENOSINA.
AR89315002A 1988-09-27 1989-09-26 Procedimiento para preparar nuevos derivados de 2'-halometiliden, 2'-etiniliden y 2'-etiniladenosina, inhibidores de la transmetilacion dependiente de adomet. AR248283A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24991188A 1988-09-27 1988-09-27
US38939189A 1989-08-03 1989-08-03

Publications (1)

Publication Number Publication Date
AR248283A1 true AR248283A1 (es) 1995-07-12

Family

ID=26940460

Family Applications (1)

Application Number Title Priority Date Filing Date
AR89315002A AR248283A1 (es) 1988-09-27 1989-09-26 Procedimiento para preparar nuevos derivados de 2'-halometiliden, 2'-etiniliden y 2'-etiniladenosina, inhibidores de la transmetilacion dependiente de adomet.

Country Status (18)

Country Link
EP (1) EP0365849B1 (es)
JP (1) JP2968002B2 (es)
KR (1) KR0146333B1 (es)
CN (1) CN1046334A (es)
AR (1) AR248283A1 (es)
AT (1) ATE111477T1 (es)
AU (1) AU621664B2 (es)
CA (1) CA1336903C (es)
DE (1) DE68918215T2 (es)
DK (1) DK171237B1 (es)
ES (1) ES2063796T3 (es)
FI (1) FI94763C (es)
HU (1) HU204843B (es)
IE (1) IE63561B1 (es)
IL (1) IL91773A (es)
NO (1) NO171857C (es)
NZ (1) NZ230766A (es)
PT (1) PT91803B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206244A (en) * 1990-10-18 1993-04-27 E. R. Squibb & Sons, Inc. Hydroxymethyl (methylenecyclopentyl) purines and pyrimidines
US5340816A (en) * 1990-10-18 1994-08-23 E. R. Squibb & Sons, Inc. Hydroxymethyl(methylenecyclopentyl) purines and pyrimidines
FR2668153B1 (fr) * 1990-10-22 1995-03-31 Pasteur Merieux Serums Vacc Nouveaux composes ribonucleosides, leur procede de preparation et les medicaments les contenant.
ATE146183T1 (de) * 1992-05-12 1996-12-15 Merrell Pharma Inc Verfahren zur herstellung von ribonukleotid- reduktasehemmern
US5589587A (en) * 1992-05-12 1996-12-31 Merrell Pharmaceuticals Inc. Process for the preparation of ribonucleotide reductase inhibitors
US5627053A (en) * 1994-03-29 1997-05-06 Ribozyme Pharmaceuticals, Inc. 2'deoxy-2'-alkylnucleotide containing nucleic acid
US5811408A (en) * 1994-07-12 1998-09-22 Yamasa Corporation 2'-deoxy-2'-(substituted or unsubstituted)methylidene-4'-thionucleosides
DE60024257T2 (de) 1999-06-09 2006-07-20 Anticancer Inc., San Diego Modulatoren der methylierung zur kontrolle von bakterieller virulenz
US6579857B1 (en) 1999-06-11 2003-06-17 Evanston Northwestern Healthcare Research Institute Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors
WO2003068162A2 (en) * 2002-02-14 2003-08-21 Pharmasset Ltd. Modified fluorinated nucleoside analogues
LT2794627T (lt) 2011-12-22 2019-01-10 Alios Biopharma, Inc. Pakeistieji nukleozidai, nukleotidai ir jų analogai
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL84414A0 (en) * 1986-11-14 1988-04-29 Ciba Geigy Ag N9-cyclopentyl-substituted adenine derivatives
EP0310673B1 (en) * 1987-03-19 1995-07-05 Yamasa Shoyu Kabushiki Kaisha 2'-alkylidenepyrimidine nucleoside derivatives, process for their preparation, and their use
NZ225906A (en) * 1987-08-26 1990-10-26 Merrell Dow Pharma Aristeromycin/adenosine derivatives and pharmaceutical compositions
ZA894534B (en) * 1988-06-20 1990-03-28 Merrell Dow Pharma Novel neplanocin derivatives

Also Published As

Publication number Publication date
CA1336903C (en) 1995-09-05
JP2968002B2 (ja) 1999-10-25
ATE111477T1 (de) 1994-09-15
FI894546A (fi) 1990-03-28
AU4176089A (en) 1990-04-05
IE63561B1 (en) 1995-05-17
FI894546A0 (fi) 1989-09-26
IE893080L (en) 1990-03-27
FI94763C (fi) 1995-10-25
DE68918215D1 (de) 1994-10-20
EP0365849A2 (en) 1990-05-02
HUT50844A (en) 1990-03-28
KR900004736A (ko) 1990-04-12
AU621664B2 (en) 1992-03-19
IL91773A (en) 1994-02-27
ES2063796T3 (es) 1995-01-16
DK473289A (da) 1990-03-28
PT91803B (pt) 1995-05-31
IL91773A0 (en) 1990-06-10
NZ230766A (en) 1992-07-28
KR0146333B1 (ko) 1998-08-01
NO171857B (no) 1993-02-01
EP0365849A3 (en) 1990-12-27
NO893826L (no) 1990-03-28
DE68918215T2 (de) 1995-02-02
CN1046334A (zh) 1990-10-24
EP0365849B1 (en) 1994-09-14
DK473289D0 (da) 1989-09-26
JPH02160769A (ja) 1990-06-20
DK171237B1 (da) 1996-08-05
FI94763B (fi) 1995-07-14
HU204843B (en) 1992-02-28
NO171857C (no) 1993-05-12
PT91803A (pt) 1990-03-30
NO893826D0 (no) 1989-09-26

Similar Documents

Publication Publication Date Title
AR248283A1 (es) Procedimiento para preparar nuevos derivados de 2'-halometiliden, 2'-etiniliden y 2'-etiniladenosina, inhibidores de la transmetilacion dependiente de adomet.
ES2043625T3 (es) Derivados de acido ariloxicarboxilico, su preparacion y empleo.
KR860004060A (ko) 티에닐 축합 피라졸 유도체의 제조방법
BG41820A3 (en) Method for preparing n- (3- hydroxy- 4- piperidinyl) benzamide derivatives
ES8702400A1 (es) Procedimiento para la obtencion de acidos 7-amino-1-ciclopropil-6,8-dihalogeno-1,4-dihidro-4-oxo-3-quinolincarboxilico
AR241018A2 (es) "n-(ciclopropil-triazinil-y-pirimidinil)-n'- (bencensulfonil) ureas con accion herbicida, procedimiento para su preparacion, intermediarios y composiciones que las contienen"
ES2033423T3 (es) Procedimientos para preparar derivados de 2-fenilpurinona.
AR246275A1 (es) Composiciones de catalizador, procedimiento para la preparacion de polimeros de monoxido de carbono, y eteno y nuevo compuesto.
BG45700A3 (en) Method for preparing of alpha- heterocyclic substituted tolunitriles
AR019813A1 (es) Compuestos utiles como activadores de catalizadores, composiciones catalizadoras para la polimerizacion de olefinas que incluyen dichos compuestos yprocedimiento de polimerizacion
ES2127919T3 (es) 4-amino-piridinas, procedimiento para su preparacion, asi como medicamentos que contienen estos compuestos.
FI93353B (fi) Menetelmä ACAT-inhiboivien kinoliinijohdannaisten valmistamiseksi
PT92880A (pt) Processo para a preparacao de derivados alquilados de polietilenoimina e de composicoes farmaceuticas que os contem
PT83961B (pt) Processo para a preparacao de derivados da pirazolina e de composicoes insecticidas e acaricidas que os contem
ES2009785B3 (es) Procedimiento para preparar derivados de tioxantona.
NO922185L (no) 1-metylkarbapenemderivater, fremgangsmaate til fremstilling derav, samt anvendelse av derivatene som antibiotika
MX166753B (es) Mejoras a composicion que contiene nitrogeno y fosforo para lubricantes a base de agua
ES8601908A1 (es) Procedimiento para la preparacion de nuevas 5,11-dihidro-6h-dibenzo (b,e)azepin-6-onas sustituidas
ES2075004T3 (es) Derivados de pirimidina, procedimientos para su produccion y composiciones herbicidas que los contienen.
PT86619A (pt) Process for preparing alkylmelatonins
ES2061478T3 (es) Derivados de teofilin-metil-ditiolano y teofilin-metil-ditianilo, un metodo para su preparacion, y composiciones farmaceuticas que los contienen.
ES2028902T3 (es) Procedimiento de preparacion de derivados del indano.
MY101173A (en) Non-radioactive biological probes.
FR2555576B1 (fr) Derives de n-(methoxyphenacyl)-amine, utilisation notamment en therapeutique et procede de preparation
ES2053544T3 (es) Un procedimiento para la preparacion de nuevos derivados de indol tetraciclicos.